Participatory Research to Understand the Translation of HPV Vaccine Policy

了解 HPV 疫苗政策转化的参与式研究

• 批准号: 7690200
• 负责人: Andrew Louis Sussman
• 金额: $ 16.88万
• 依托单位: UNIVERSITY OF NEW MEXICO
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-22 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7690200
• 关键词: 12 year old; Administrator; Advisory Committees; Affect; Anogenital venereal warts; Area; Behavioral Research; Case Study; Cervical; Child; Child health care; Collaborations; Communities; Community Health; Country; Data; Data Collection; Decision Making; Development; District of Columbia; Education; Ensure; Ethnography; FDA approved; Face; Focus Groups; Funding; Gardasil; Goals; Government; Head; Health Personnel; Health Policy; Healthcare; Hispanics; Human Papilloma Virus Vaccine; Human Papillomavirus; Immunization; Incidence; Individual; Infection; Information Dissemination; Institution; Insurance; Interview; Lesion; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Marketing; Mediation; Medical Societies; Mexico; Morbidity - disease rate; New Mexico; Nurses; Parenting Education; Parents; Patients; Perception; Play; Policies; Policy Maker; Premalignant; Primary Health Care; Process; Provider; Public Policy; Qualitative Research; Recommendation; Religious Belief; Reporting; Research; Resources; Role; Schools; Scientific Advances and Accomplishments; Scientist; Series; Societies; Sorting - Cell Movement; Statutes and Laws; Structure; System; Toes; Translations; Vaccination; Vaccines; Woman; Work; base; cancer health disparity; cultural values; disorder prevention; experience; girls; health disparity; meetings; methionylmethionine; mortality; policy implication; primary care setting; programs; public health relevance; response; social; vaccine delivery

DESCRIPTION (provided by applicant): In June of 2006, the FDA approved Merck's vaccine "Guardasil" which protects against 4 types of HPV infections, two which cause abnormal cervical dysplagia and two which cause genital warts. In the 15 months since the approval and the subsequent recommendation by the Advisory Committee on Immunization Practice (ACIP) that the vaccine be routinely administered to 11-12 year old girls, legislators in 41 states and the District of Columbia have introduced legislation to require, fund, or educate the public about the HPV vaccine, and at least 17 states have enacted some sort of legislation, including the state of New Mexico. In this application we propose to study the process of implementing policy regarding the HPV vaccine in the state of New Mexico, and related programmatic efforts to offer the vaccine and relevant education to parents and the public. This study is responsive to the call for proposals to conduct research on three areas of action: public policy, health care, and disease prevention. The Specific Aims are as follows: 1. Using a participatory process, identify and convene a stakeholder group composed of individuals involved in the health policy context 2. Explore the translation and impact of health policy initiatives regarding the dissemination of HPV vaccine and the promotion of informed decision making in New Mexico public schools and primary care settings. a. Conduct semi structured interviews with health policy makers, primary care providers, school based health providers and school administrators, in order to determine their perceptions of the roles b. Conduct focus group discussions with parents of 5th grade children c. Conduct ethnographic observations of the ongoing debate about the HPV vaccine dissemination policy 3. Together with the stakeholder group, interpret the data, develop and disseminate health policy recommendations regarding initiatives to support HPV vaccine dissemination and informed decision making leading to the reduction of cervical cancer health disparities in New Mexico. PUBLIC HEALTH RELEVANCE: The recent approval of the HPV vaccine is an important scientific advance but faces challenges in dissemination and implementation. This study will help to develop a better understanding of the factors that contribute to the development of HPV vaccine policy. These findings will be used to work toward the creation of strategies, both at the primary care and health policy level, to promote informed decision among patients with regard to the HPV vaccine that are consistent with community values.

描述（由申请人提供）：2006年6月，FDA批准了默克的疫苗“瓜塔西尔”，该疫苗可预防4种类型的HPV感染，两种感染引起异常的宫颈前elplagia和两种引起生殖器疣。自从批准和随后的免疫实践咨询委员会（ACIP）提出的15个月内，通常将疫苗定期向11-12岁的女孩进行管理，41个州和哥伦比亚特区的立法者已提出立法以要求，资助公众或教育公众有关HPV疫苗的问题，以及至少17个州的米尔，包括某些米尔的宣传，包括一项新的法规，包括一项新的一项法规。在本申请中，我们建议研究新墨西哥州实施有关HPV疫苗的政策的过程，以及相关的计划努力，以向父母和公众提供疫苗和相关教育。这项研究旨在响应呼吁提案对三个行动领域进行研究：公共政策，医疗保健和预防疾病。具体目的如下：1。使用参与过程，识别和召集由涉及卫生政策背景的个人组成的利益相关者群体2。探讨有关HPV疫苗传播的卫生政策计划的翻译和影响，以及在新墨西哥公立学校和初级护理机构中促进知情的决策。一个。与卫生政策制定者，初级保健提供者，基于学校的卫生提供者和学校管理人员进行半结构化访谈，以确定他们对角色的看法b。与5年级儿童的父母进行焦点小组讨论c。对有关HPV疫苗传播政策的持续辩论进行民族志观察3。与利益相关者组一起，解释数据，制定和传播有关支持HPV疫苗传播和知情决策的倡议的卫生政策建议，并导致新墨西哥州宫颈癌健康差异的降低。公共卫生相关性：HPV疫苗的最新认可是一项重要的科学进步，但面临传播和实施方面的挑战。这项研究将有助于更好地理解有助于HPV疫苗政策发展的因素。这些发现将用于在基层保健和卫生政策水平上创建策略，以促进与社区价值一致的HPV疫苗的患者中明智的决定。

项目成果

Viewing Focus Groups Through a Critical Incident Lens.

• DOI: 10.1177/1049732315579178
• 发表时间: 2016-05
• 期刊: QUALITATIVE HEALTH RESEARCH
• 影响因子: 3.2
• 作者: Getrich, Christina M.;Bennett, Anzia M.;Sussman, Andrew L.;Solares, Angelica;Helitzer, Deborah L.
• 通讯作者: Helitzer, Deborah L.